DSM-5 mixed specifier for manic episodes: Evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

Journal of Affective Disorders

Volumn 150, Issue 2, 2013, Pages 378-383

  McIntyre, R S ^a   Tohen, M ^b   Berk, M ^c,d,e,f   Zhao, J ^g   Weiller, E ^h  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c DEAKIN UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^g MERCK RESEARCH LABORATORIES   (United States)

^h H LUNDBECK A S   (Denmark)

Author keywords

Asenapine; Bipolar I disorder; Depressive features; DSM 5 mixed specifier; Manic episode; Olanzapine

Indexed keywords

ASENAPINE; OLANZAPINE; PLACEBO;

ADULT; ARTICLE; DEPRESSION; DISEASE SEVERITY; DSM-5; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSITIVE AND NEGATIVE SYNDROME SCALE; POST HOC ANALYSIS; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; VALIDITY;

ASENAPINE; BIPOLAR I DISORDER; DEPRESSIVE FEATURES; DSM-5 MIXED SPECIFIER; MANIC EPISODE; OLANZAPINE;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84882833688     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.04.025     Document Type: Article

References (16)

1. J.M. Azorin, C. Sapin, and E. Weiller Effect of asenapine on manic and depressive symptoms in bipolar I patients with mixed episodes: results from post hoc analyses Journal of Affective Disorders 145 1 2013 62 69
2. A. Cipriani, C. Barbui, G. Salanti, J. Rendell, R. Brown, S. Stockton, M. Purgato, L.M. Spineli, G.M. Goodwin, and J.R. Geddes Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis The Lancet 378 9799 2011 1306 1315
3. W. Guy Clinical global impressions W Guy, ECDEU Assessment Manual for Psychopharmacology 1976 U.S. Department of Health, Education, and Welfare Washington, DC 217 222
4. S.R. Kay, A. Fiszbein, and L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophrenia Bulletin 13 1987 261 276
5. Kupfer, D.J., Angst, J., Berk, M., Dickerson, F., Frangou, S., Frank, E., Goldstein, B.I., Harvey, A., Laghrissi-Thode, F., Leboyer, M., Ostacher, M.J., Sibille, E., Strakowski, S.M., Suppes, T., Tohen, M., Yolken, R.H., Young, L.T., Zarate, C.A., 2011. Advances in bipolar disorder. In: Selected Sessions from the 2011 International Conference on Bipolar Disorder. Annals of the New York Academy of Sciences. 1242, 1-25.
6. S.L. McElroy, P.E. Keck, H.G. Pope, J.I. Hudson, G.L. Faedda, and A.C. Swann Clinical and research implications of the diagnosis of dysphoric mania or hypomania American Journal of Psychiatry 149 1992 1633 1644
7. S.L. McElroy Understanding the complexity of bipolar mixed episodes Journal of Clinical Psychiatry 69 2 2008 e06
8. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states Bipolar Disorders. 11 7 2009 673 686
9. R.S. McIntyre, M. Cohen, J. Zhao, L. Alphs, T.A. Macek, and J. Panagides Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial Journal of Affective Disorders 122 1-2 2010 27 38
10. S.M. Montgomery Depressive symptoms in acute schizophrenia Progress in Neuro-psychopharmacology 3 1979 429 433
11. T. Suppes, J. Mintz, S.L. McElroy, L.L. Altshuler, R.W. Kupka, M.A. Frye, P.E. Keck, W.A. Nolen, G.S. Leverich, H. Grunze, A.J. Rush, and R.M. Post Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon Archives of General Psychiatry. 62 10 2005 1089 1096
12. A.C. Swann, T. Suppes, M.J. Ostacher, J.M. Eudicone, R. McQuade, A. Forbes, and B.X. Carlson Multivariate analysis of bipolar mania: retrospectively assessed structure of bipolar I manic andmixed episodes in randomized clinical trial participants Journal of Affective Disorders 144 1-2 2013 59 64
13. A. Szegedi, J. Zhao, A. vanWillengenburg, K. Nations, M. Mackle, and J. Panagides Effects of asenapine in patients with bipolar I disorder experiencing acute manic or mixed episodes. A post-hoc analysis of two 3-week clinical trials BMC Psychiatry 11 2011 101
14. M. Tohen, C.M. Waternaux, and M.T. Tsuang Outcome in mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis Archives of General Psychiatry 47 12 1990 1106 1111
15. A. Yildiz, E. Vieta, S. Leucht, and R.J. Baldessarini Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials Neuropsychopharmacology 36 2 2011 375 389
16. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity British Journal of Psychiatry 133 1978 429 435